Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Research-grade specs Sequence: Glu-Cys-Gly (-glutamyl bond) Length: 3 amino acids Redox states: Cycles between GSH (reduced) and GSSG (oxidised disulfide) Vial size: 10 mL / 1500 mg Format: Lyophilized powder Studied applications Redox-state measurement and oxidative stress assays (GSH:GSSG ratio) Glutathione-S-transferase and Phase II enzyme research Mitochondrial-function research Analytical method development biosensor and mass-spectrometry quantification Reference-standard use in assay validation Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included COA shown in the product gallery cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store refrigerated at 28C, protected from light and air Glutathione oxidises readily on exposure to air reseal promptly and use reconstituted material within a short window Reconstitute with bacteriostatic water for laboratory preparation Follow your laboratorys standard handling and disposal protocol Related research: NAD+ 5-Amino-1MQ GHK-Cu All research vials Certificates of Analysis Bulk & Wholesale Pricing Frequently Asked Questions Do I need a coupon code for bulk discounts
We then discuss evidence that highly reactive free radical species, especially reactive oxygen species (ROS) generated in endometriosis patients damage intracellular structures and genomic material to adversely impact the structural integrity and viability of oocytes, sperm, and embryos, evaluate literature data that implicates oocyte and fetal aneuploidy as contributing factors for infertility caused by endometriosis, and we discuss therapeutic horizons for treatment of endometriosis patients with antioxidant therapies
That said, more is not automatically better, and the right dose and frequency depend on you
A small study published in the early 2000s found that MT-II administered via subcutaneous injection led to improved erectile function in some participants
